The largest database of trusted experimental protocols

5 protocols using dntps

1

Ectopic Expression of TP53 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following compounds and working concentrations were used: Fibronectin (10 μg/ml, Sigma Aldrich F0895), JPH203 (Selleck Chemicals S8667), NCT503 (Sigma Aldrich SML1659), Dasatinib (Selleck Chemicals S1021), PF-573228 (Selleck Chemicals S2013), Cytochalasin D (Sigma Aldrich C2618), Latrunculin-A (Cayman 10010630), SAHA Cayman 149647-78-9), 17-AAG Geldanamycin (Lc Laboratories A-6880), GCN2-IN-1 (Synonyms: A-92; MedChem Express Cat. No.: HY-100877), nucleosides dNTPs (Euroclone EMR276425), N-Acetyl-L-Cysteine (NAC) (Sigma Aldrich A9165), S-(5′-Adenosyl)-L-Methionine Iodide (SAM) (Sigma Aldrich A4377) and DMSO (Sigma Aldrich D4540). Treatments lasted as described in figure legends.
pCW57-GFP-P2A-MCS (empty backbone) was bought from Addgene (plasmid #89181). pCW57-GFP-HA-p53 wt, pCW57-GFP-HA-mutp53 R175H, pCW57-GFP-HA-mutp53 R249S, pCW57-GFP-HA-mutp53 R273K or pCW57-GFP-HA-mutp53 R280K were generated by cloning a PCR amplified DNA fragment of the human HA-tagged TP53 sequence (WT or mutated) into the pCW57-GFP-P2A-MCS with MluI and BamHI restriction sites.
+ Open protocol
+ Expand
2

Ectopic Expression of TP53 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following compounds and working concentrations were used: Fibronectin (10 μg/ml, Sigma Aldrich F0895), JPH203 (Selleck Chemicals S8667), NCT503 (Sigma Aldrich SML1659), Dasatinib (Selleck Chemicals S1021), PF-573228 (Selleck Chemicals S2013), Cytochalasin D (Sigma Aldrich C2618), Latrunculin-A (Cayman 10010630), SAHA Cayman 149647-78-9), 17-AAG Geldanamycin (Lc Laboratories A-6880), GCN2-IN-1 (Synonyms: A-92; MedChem Express Cat. No.: HY-100877), nucleosides dNTPs (Euroclone EMR276425), N-Acetyl-L-Cysteine (NAC) (Sigma Aldrich A9165), S-(5′-Adenosyl)-L-Methionine Iodide (SAM) (Sigma Aldrich A4377) and DMSO (Sigma Aldrich D4540). Treatments lasted as described in figure legends.
pCW57-GFP-P2A-MCS (empty backbone) was bought from Addgene (plasmid #89181). pCW57-GFP-HA-p53 wt, pCW57-GFP-HA-mutp53 R175H, pCW57-GFP-HA-mutp53 R249S, pCW57-GFP-HA-mutp53 R273K or pCW57-GFP-HA-mutp53 R280K were generated by cloning a PCR amplified DNA fragment of the human HA-tagged TP53 sequence (WT or mutated) into the pCW57-GFP-P2A-MCS with MluI and BamHI restriction sites.
+ Open protocol
+ Expand
3

Ectopic Expression of TP53 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following compounds and working concentrations were used: Fibronectin (10 μg/ml, Sigma Aldrich F0895), JPH203 (Selleck Chemicals S8667), NCT503 (Sigma Aldrich SML1659), Dasatinib (Selleck Chemicals S1021), PF-573228 (Selleck Chemicals S2013), Cytochalasin D (Sigma Aldrich C2618), Latrunculin-A (Cayman 10010630), SAHA Cayman 149647-78-9), 17-AAG Geldanamycin (Lc Laboratories A-6880), GCN2-IN-1 (Synonyms: A-92; MedChem Express Cat. No.: HY-100877), nucleosides dNTPs (Euroclone EMR276425), N-Acetyl-L-Cysteine (NAC) (Sigma Aldrich A9165), S-(5′-Adenosyl)-L-Methionine Iodide (SAM) (Sigma Aldrich A4377) and DMSO (Sigma Aldrich D4540). Treatments lasted as described in figure legends.
pCW57-GFP-P2A-MCS (empty backbone) was bought from Addgene (plasmid #89181). pCW57-GFP-HA-p53 wt, pCW57-GFP-HA-mutp53 R175H, pCW57-GFP-HA-mutp53 R249S, pCW57-GFP-HA-mutp53 R273K or pCW57-GFP-HA-mutp53 R280K were generated by cloning a PCR amplified DNA fragment of the human HA-tagged TP53 sequence (WT or mutated) into the pCW57-GFP-P2A-MCS with MluI and BamHI restriction sites.
+ Open protocol
+ Expand
4

RNA Extraction, cDNA Synthesis, and qRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was purified using ReliaPrep RNA Miniprep System (Promega, #Z6011), according to the manufacturer's instructions. RNA was retrotranscribed for 1 h at 42°C with retro transcriptase M‐MLV (Invitrogen, #28025‐013) in the presence of oligo(dT)15 Primer (Promega, #C1101), dNTPs (Euroclone), and RNAsin Ribonuclease Inhibitor (Promega, #N2111). The cDNA was diluted 10 times to perform qRT‐PCR with SYBR Green Master Mix (Applied Biosystems, #4309155). The list of primers adopted in the study is provided in Appendix Table S2. Ct values were normalized to the housekeeping gene UbiquitinC by the ΔΔCt method.
+ Open protocol
+ Expand
5

Comprehensive Genotyping of CYP3A, ABCB1, and SXR

Check if the same lab product or an alternative is used in the 5 most similar protocols
As regards genotyping of CYP3A5, ABCB1 and SXR polymorphisms 500 μl of whole blood were collected during routine ambulatory control.
DNA extraction was performed by extractor Fuji QuickGene-810 (Fujifilm, Tokyo, Japan), PCR was carried out in 20 μl of a solution containing 2 μl of 10 x PCR Gold Buffer, 2 mM of MgCl2 (Applied Biosystem, Foster City, CA, USA), 80 μM each of dNTPs (Euroclone, Pero, Milan, Italy), 50 pmol each of primers for CYP3A and ABCB1 as previous described [32 (link)], 50 ng of genomic DNA and 0.6 U of AmpliTaq Gold (Applied Biosystem, Foster City, CA USA). For the polymorphism of SXR A7635G and SXR –200 GAGAAG/− (rs3842689) we used the following primers: SXR A7635G forward 3′- TGG ATG CCA AGC TCA GTGG − 5′; reverse 3′- CAG CAG CCA TCC CAT AAT CC − 5′; for SXR rs3842689 we used the following primers pair: forward 3′-CTG ATG CTC TCT GGT CCT GC − 5′, reverse 3′-TGC CTG CTA TAG CTG ATT CAT TG-5′ with a melt temperature of 60 °C for both polymorphisms..
The template was purified by liquid handling Biomek® 3000 (Beckman Coulter, CA, USA) using a magnetic particles system (Agencourt/Beckman Coulter, CA, USA). The single DNA strand was amplified by BigDye® 3.1 (Applied Biosystems, Foster City, CA USA) and then sequenced by a 3130xl Genetic Analyzer (Applied Biosystems/Hitachi, Foster City, CA USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!